Emerging blood-based biomarkers such as exosomal PD-L1, TMB, and T-cell receptor (TCR) sequence in cell-free DNA, and hypermutated circulating tumor DNA associate with response19–23; however, these approaches require complex platforms, and/or bioinformatics analysis, that limit their widespread application in community-based clinical practice. The gene discussed is CD274; the disease is neoplasm.